Filing Flows › Ironwood Pharmaceuticals (IRWD) › Operating margin
Ironwood Pharmaceuticals (IRWD) operating margin by quarter
Ironwood Pharmaceuticals' operating margin was 70.0% in Q3 2026 (third quarter 2026), -0.2 pts from Q2 2026. Over the last 5 quarters it ranged from 53.2% (Q2 2025) to 70.2% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 70.0% | -0.2 pts | +8.2 pts |
| Q2 2026 | 70.2% | +2.0 pts | +17.0 pts |
| Q1 2026 | 68.1% | +6.3 pts | — |
| Q3 2025 | 61.8% | +8.7 pts | — |
| Q2 2025 | 53.2% | — | — |
Q3 2026 at a glance
Ironwood Pharmaceuticals, Q3 2026: revenue $133M (+9% year over year), operating margin 70.0%, net earnings $59.8M, operating cash flow $67.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ironwood Pharmaceuticals' operating margin?
Ironwood Pharmaceuticals' operating margin was 70.0% in Q3 2026 (third quarter 2026), -0.2 pts from Q2 2026.
How has Ironwood Pharmaceuticals' operating margin changed?
Over the last 5 quarters it ranged from 53.2% (Q2 2025) to 70.2% (Q2 2026).
Q3 2026 results → · How Ironwood Pharmaceuticals makes money →